The four-year, $1.3 million grant was awarded to John Edwards, MD, and Ashraf Ibrahim, PhD, infectious disease specialists at LA BioMed to develop a vaccine to protect against Candida and methicillin-resistant Staphylococcus aureus. The researchers are collecting and studying samples of patients currently enrolled in a clinical trial testing the efficacy of a Candida vaccine.
“LA BioMed’s infectious disease specialists are creating a new generation of vaccines to combat these infections,” said David Meyer, PhD, LA Biomed president and CEO. “Securing federal funding for such important studies is critical to advancing innovations and developing the medical breakthroughs needed to protect patient health.”
More articles on HAIs:
Top 10 infection control stories, September 15-19
Experimental CAUTI vaccine demonstrates positive early test results
Hospital-acquired infection control market: 6 observations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.